About Index Trending news
Analyze
Top 50 Pricing
MabVax Therapeutics

MabVax Therapeutics

Work at MabVax Therapeutics? Add yourself to this profile

MabVax Therapeutics

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

Elsewhere

Alexa global traffic share

Twitter followers

06 Apr 2015
$11,600,000
Post-IPO equity
09 Jul 2014
$3,000,000
Private equity
25 Sep 2013
$1,750,000
Grant
20 Nov 2012
$5,250,000
Venture capital (Series B)